|
|
||||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From Childrens Hospital, San Diego, CA.
Correspondence to: Carolyn E. Behrendt, PhD, 4065 3413 Paseo del Campo, Palos Verdes, CA 90274; e-mail: CarolynBehrendt{at}yahoo.com
| Abstract |
|---|
|
|
|---|
Design and setting: Retrospective cohort drawn from the Nationwide Inpatient Sample of 6.4 million discharges from 904 representative nonfederal hospitals during 1994.
Patients: All 61,223 patients in the sample whose discharge
records indicated all of the following: acute respiratory distress or
failure, mechanical ventilation,
24 h of hospitalization, and age
5 years.
Results: An estimated 329,766 patients
discharged from nonfederal hospitals nationwide in 1994 met study
criteria for ARF. The incidence of ARF was 137.1 hospitalizations per
100,000 US residents age
5 years. Incidence increased
nearly exponentially each decade until age 85 years. Overall, 35.9% of
patients with ARF did not survive to hospital discharge. At 31 days,
hospital mortality was 31.4%. According to the proportional hazards
model, significant mortality hazards included age (
80 years and
30 years), multiorgan system failure (MOSF), HIV, chronic liver
disease, and cancer. Hospital admission for coronary artery bypass,
drug overdose, or trauma other than head injury or burns was associated
with a reduced mortality hazard. Interaction was present between age
and MOSF, trauma, and cancer. A point system derived from the hazard
model classified patients into seven groups with distinct 31-day
survival probabilities ranging from 24 to 99%.
Conclusions: The incidence of ARF increases markedly with
age and is especially high among persons
65 years of age.
Nonpulmonary hazards explain short-term (31-day)
survival.
Key Words: acute disease adult aged child hospital mortality incidence respiratory insufficiency survival analysis United States
| Introduction |
|---|
|
|
|---|
15
years in Sweden, Denmark, and Iceland and 88.6 cases per 100,000
residents in Berlin.1
2
The incidence of ARF in the United
States, however, is unknown. Rates of hospital mortality among ICU
patients with a diagnosis of ARF or requiring mechanical ventilation
range from 28 to 58%.1
2
3
4
5
6
7
8
9
10
11
12
Higher mortality rates have
been observed among ARF patients with AIDS or hematologic malignancy
(65% and 83% mortality, respectively).13
14 Independent hazards for ARF mortality include older age,1 2 4 5 6 8 11 12 14 severe chronic comorbidities (HIV, active malignancy, cirrhosis),1 5 6 8 9 10 12 certain precipitating events (trauma,3 6 8 11 drug overdose,8 9 bone marrow transplant [BMT]13 ), and multiple organ system dysfunction or failure (MOSF).3 4 7 9 10 11 12 13 Mortality has also been associated with acute lung injury 9 12 or bilateral infiltrates on chest radiograph,1 and with an elevated acute physiology score1 6 7 or APACHE (acute physiology and chronic health evaluation) score.9 10
To my knowledge, no study to date has applied survival analysis to a representative cohort of US ARF patients, surgical as well as medical, children as well as adults. Such a cohort can be extracted from the Nationwide Inpatient Sample, a database of all patients discharged from a representative sample of 904 nonfederal hospitals throughout the United States during 1994.15 Using data on these ARF patients, the current study estimates age-specific incidences of ARF and constructs a proportional hazards model to explain the associated hospital mortality. These findings will enhance the epidemiologic picture of ARF, increasing the information available to support clinical decision making, counseling of ARF patients and their families, and investigation of new therapies.
| Materials and Methods |
|---|
|
|
|---|
Definitions
Patients in the Nationwide Inpatient Sample were considered to
have ARF if they had a diagnostic code for acute respiratory distress
or failure (ICD-9-CM 518.5, 518.81, or 518.82) together with a
procedure code for continuous mechanical ventilation (ICD-9-CM
96.7). Such ventilation included positive end-expiratory pressure but
excluded continuous positive airway pressure, intermittent
positive-pressure breathing, and oxygen by face mask or nasal cannula.
Total hours of ventilation were not recorded in the database, so no
minimum period of mechanical ventilation was specified. Instead, ARF
patients were limited to those who remained in the hospital at least
24 h. Infants and children < 5 years were excluded.
Additional clinical conditions were ascertained using ICD-9-CM codes.
MOSF was defined as one or more of the following in addition to
respiratory failure: acute renal failure, cardiac arrest, shock, acute
cerebrovascular event, disseminated intravascular coagulation, acute
intestinal vascular insufficiency, acute hepatic failure, head injury
with loss of consciousness for > 24 h or until death, and burns
involving
20% of body surface. Trauma refers to a primary
diagnosis of crushing or internal injury, open wounds, superficial
injury or contusion, sprains or strains, fractures other than isolated
hip fracture, spinal cord injury, other injuries, or ARF with lung
contusion. Head injury with loss of consciousness for > 24 h or until
death and burns involving
20% of body surface were categorized as
MOSF rather than trauma.
Statistical Analysis
National sampling weights were used in all analyses (SUDAAN
7.5.3 software; Research Triangle Institute; Research Triangle Park,
NC) except the generation of survival plots (SAS 6.12 software; SAS
Institute; Cary, NC). For the national estimates of ARF incidence, US
Census Bureau estimates of the resident population as of July 1, 1994,
served as the population denominators.16
The SEs of proportions and 95% confidence intervals around proportional hazard estimates were calculated using Taylor series linearization.17 18 This method takes into account the intracluster correlation that may result from the survey design, which included all patients at selected hospitals rather than selected patients from all hospitals.
The follow-up period began at 24 h after hospital admission and
continued through 31 days. After this time, the accelerated nature of
several hazards (age
80 years, MOSF, coronary artery bypass graft
[CABG], and drug overdose) undermined the requisite assumption of
proportional hazards.19
Survivors included patients who
were discharged alive at any time and also those who died in the
hospital after the follow-up period; survival times were censored at 31
days. Terms were retained in the multivariate model if they were
significant at p < 0.0001 and improved the -2 log-likelihood ratio.
| Results |
|---|
|
|
|---|
24 h. After excluding the 2.3% of these patients
who were < 5 years of age, a total of 61,223 ARF patients remained.
Their median age was 69 years (5th to 95th percentile range, 30 to 87
years). Children aged 5 to 17 years comprised 1.4% of patients. Half
(51.1%) of all patients were male.
The highest frequency of head injury, burns, and other trauma combined
(20.8%) was among patients aged < 30 years, whereas the greatest
prevalence of congestive heart failure (47.2%) and COPD (39.0%) was
among patients aged
50 years. The frequency of asthma decreased
steadily with age, from 16.6% among children aged 5 to 17 years to
2.9% among adults aged
80 years.
Incidence
The ARF patients in the sample corresponded to 329,766 discharges
nationwide or 137.1 hospitalizations per 100,000 US residents aged
5 years. ARF incidence increased markedly with age, resulting in an
88-fold difference in risk between the youngest and oldest age groups
(Fig 1 ).
|
A cohort of 61,113 ARF patients was appropriate for survival analysis. Patients admitted to the hospital for BMT (n = 86 or 0.14%) were excluded. Because of the variable lag time between admission for BMT and onset of ARF, their survival curve could not be aligned with that of the rest of the cohort. Another 24 patients (0.04%) who lacked data on survival status at follow-up were also excluded.
At the end of 31 days, hospital mortality among the cohort was 31.4 ± 0.2%. As shown in Table 1 , hazards for 31-day mortality included age, MOSF, HIV, chronic liver disease, and cancer. Mortality hazard was significantly reduced among patients admitted for CABG, drug overdose, or trauma other than head injury or burns (hereafter referred to simply as trauma).
|
Trauma patients aged 30 to 79 years who did not develop MOSF had a mortality rate as low as that among uncomplicated patients aged < 30 years; these groups were combined to serve as the models referent category. The fit of the model was further improved by combining cancer and chronic liver disease into a single term (severe chronic comorbidity) and by combining drug overdose and CABG into another term (low-risk precipitating event). The model was not improved by including a term for sepsis.
A point system, shown in the far right column of Table 1 , converted the hazard profiles of individual patients into scores from -1 to 5 (Table 2 ). The observed survival curves associated with these scores (Fig 2 ) were each significantly different from the next (log-rank test, p < 0.001 for all pairs). The steepest curve was the least smooth, owing to the small number of patients (n = 101) with the maximum score.
|
|
| Discussion |
|---|
|
|
|---|
The gap between the current estimate (137.1/ 100,000 residents aged
5 years) and that previously published from Berlin (88.6/100,000
residents) narrows once the Berlin estimate has been adjusted for
age.2
Adjustment is necessary because, whereas the entire
population of Berlin served as the estimates denominator, its
numerator was restricted to ARF cases
14 years. Assuming that
children < 14 years comprised 20% of the Berlin population (as was
the case in the US population16
), the age-adjusted
incidence of ARF in Berlin would be approximately 110.8/100,000
residents aged
14 years. It is unclear why another European survey
of ARF yielded a much lower estimate of 77.6 per 100,000 population
aged
15 years.1
The incidence of ARF was found to increase nearly exponentially with each decade until age 85 years. Comparable incidence estimates by age have not been published.
The current 36% rate of mortality before discharge was similar to the 37% rate previously reported among ARF patients admitted to 40 US hospitals6 and approached the 41% and 43% rates reported among ARF patients in two European surveys.1 2 Whether ARF incidence or mortality differs significantly between the United States and Europe cannot be determined at this time, because of varying case definitions among studies to date.
Because discharge data reflect the entire course of hospitalization rather than the initial day of follow-up, the current survival analysis and the point system derived from it are explanatory rather than prognostic. The current survival analysis confirmed reports of associations between ARF mortality and older age, MOSF, HIV, cancer, chronic liver disease, trauma, and drug overdose.1 2 3 4 5 6 7 8 9 10 11 12 13 The increase in mortality at age 30 years and again at age 80 years observed in the current study has been noted in previous studies of patients receiving mechanical ventilation and ARF patients.5 8 12 Also consistent with earlier studies was the current lack of association between ARF mortality and sex, pneumonia, COPD, congestive heart failure, and diabetes.1 2 3 4 5 9 10 14 The current data did not confirm an independent association between ARF mortality and sepsis.3 9
The current survival analysis reflects the limitations as well as the strengths inherent in the Nationwide Inpatient Sample database. The lack of data on acute lung injury and acute physiologic or APACHE score and the necessity of excluding BMT patients precluded testing of these potential hazards in the multivariate model. However, the presence of large numbers of children, young adults, and the elderly within the sample permitted the significant interaction between age and other hazards for ARF mortality to be detected for the first time.
| Conclusion |
|---|
|
|
|---|
65 years of age. Nonpulmonary hazards explain
short-term (31-day) survival.
| Acknowledgements |
|---|
| Footnotes |
|---|
Received for publication November 16, 1999. Accepted for publication March 28, 2000.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A. N. Aggarwal, R. Agarwal, D. Gupta, and S. K. Jindal Nonpulmonary Organ Dysfunction and Its Impact on Outcome in Patients With Acute Respiratory Failure Chest, September 1, 2007; 132(3): 829 - 835. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. El Solh and F. H. Ramadan Overview of Respiratory Failure in Older Adults J Intensive Care Med, December 1, 2006; 21(6): 345 - 351. [Abstract] [PDF] |
||||
![]() |
C. Weinert and W. Meller Epidemiology of Depression and Antidepressant Therapy After Acute Respiratory Failure Psychosomatics, October 1, 2006; 47(5): 399 - 407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Kahn, C. H. Goss, P. J. Heagerty, A. A. Kramer, C. R. O'Brien, and G. D. Rubenfeld Hospital volume and the outcomes of mechanical ventilation. N. Engl. J. Med., July 6, 2006; 355(1): 41 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Carson, C. E. Cox, G. M. Holmes, A. Howard, and T. S. Carey The changing epidemiology of mechanical ventilation: a population-based study. J Intensive Care Med, May 1, 2006; 21(3): 173 - 182. [Abstract] [PDF] |
||||
![]() |
C. D. Epstein and J. R. Peerless Weaning Readiness and Fluid Balance in Older Critically Ill Surgical Patients Am. J. Crit. Care., January 1, 2006; 15(1): 54 - 64. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. C. Engoren and C. M. Arslanian-Engoren Outcome After Tracheostomy for Respiratory Failure in the Elderly J Intensive Care Med, March 1, 2005; 20(2): 104 - 110. [Abstract] [PDF] |
||||
![]() |
C. E. Cox, S. S. Carson, and A. K. Biddle Cost-effectiveness of Ultrasound in Preventing Femoral Venous Catheter-associated Pulmonary Embolism Am. J. Respir. Crit. Care Med., December 15, 2003; 168(12): 1481 - 1487. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Cox, S. S. Carson, E. W. Ely, J. A. Govert, J. M. Garrett, R. G. Brower, D. G. Morris, E. Abraham, V. Donnabella, A. Spevetz, et al. Effectiveness of Medical Resident Education in Mechanical Ventilation Am. J. Respir. Crit. Care Med., January 1, 2003; 167(1): 32 - 38. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Hattler, L. W. Lund, J. Golob, H. Russian, M. F. Lann, T. L. Merrill, B. Frankowski, and W. J. Federspiel A respiratory gas exchange catheter: In vitro and in vivo tests in large animals J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 520 - 530. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Epstein, N. El-Mokadem, and J. R. Peerless Weaning Older Patients From Long-term Mechanical Ventilation: A Pilot Study Am. J. Crit. Care., July 1, 2002; 11(4): 369 - 377. [Abstract] [Full Text] [PDF] |
||||
![]() |
2-Month Mortality and Functional Status of Critically Ill Adult Patients Receiving Prolonged Mechanical Ventilation Chest, February 1, 2002; 121(2): 549 - 558. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Esteban, A. Anzueto, F. Frutos, I. Alia, L. Brochard, T. E. Stewart, S. Benito, S. K. Epstein, C. Apezteguia, P. Nightingale, et al. Characteristics and Outcomes in Adult Patients Receiving Mechanical Ventilation: A 28-Day International Study JAMA, January 16, 2002; 287(3): 345 - 355. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W. Ely, A. P. Wheeler, B. T. Thompson, M. Ancukiewicz, K. P. Steinberg, G. R. Bernard, and for the Acute Respiratory Distress Syndrome Networ Recovery Rate and Prognosis in Older Persons Who Develop Acute Lung Injury and the Acute Respiratory Distress Syndrome Ann Intern Med, January 1, 2002; 136(1): 25 - 36. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |